Want to see BDRX full AI Analyst Report?
Erapa (Encapsulated Rapamycin)
Familial Adenomatous Polyposis (Fap)
Phase III
Recruiting
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
Apr 10, 2025
―
Mtx110, Programmable Pump And Catheter System
Recurrent Glioblastoma
Phase I
Terminated
A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma
Mar 28, 2022
―
Encapsulated Rapamycin (Erapa)
Familial Adenomatous Polyposis
Phase II
Active Not Recruiting
Trial of ERapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance
Jan 12, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Biodexa Pharmaceuticals (BDRX) have in its pipeline
BDRX is currently developing the following drugs: Erapa (Encapsulated Rapamycin), Mtx110, Programmable Pump And Catheter System, Encapsulated Rapamycin (Erapa). These drug candidates are in various stages of clinical development as the company works toward FDA approval.